Big Tech is once again doing the market’s heavy lifting. That has more than a few on Wall Street very worried.
4 minute read
Technology
Meta Muse’s Hottest Rival Just Got a $10B Valuation. Most People Can’t Even Use It Yet.
Unlike Muse, Instinct isn’t app-based. Instead it works through text messages and phone calls.
Today's Other Headlines
Healthcare Roundtable
Innovation Is Driving a New Bull Market in Biotech. 16 Picks From Our Roundtable Pros.
Biotechnology stocks are soaring this year as medical advances and merger activity rekindle investor interest. More gains lie ahead, our panel says.
Barron's Live
Brookfield Has an Enviable Record of Boosting Profits. Its Stock Looks Cheap.
The Canadian alternative-asset manager is valued at 55% of a recent estimate of its asset value.
Long Read
Costco Earnings Beat Wasn’t Enough for the Stock
The growth rate for membership revenue declines for a third-straight quarter for Costco as fees rise 7.3% year over year to $1.5 billion.
2 minute read
BlackBerry Posts Strong Earnings, Driven by Car Software
BlackBerry reports fiscal second-quarter earnings per share of 7 cents from sales of $163.3 million. Wall Street was looking for 4 cents and $142.5 million, respectively.
2 minute read
Why Everpure Is Today’s Best Stock in the S&P 500
Everpure stock advances after the data-storage company says revenue growth will continue to accelerate in fiscal 2028.
Darden Stock Declines After Earnings. Olive Garden’s Growth Is Slowing Down.
Darden Restaurants falls after reporting fiscal first-quarter earnings that declined from a year earlier.
September 28, 2026
Innovation Is Driving a New Bull Market in Biotech. 16 Picks From Our Roundtable Pros.
Biotechnology stocks are soaring this year as medical advances and merger activity rekindle investor interest. More gains lie ahead, our healthcare panel says.
Long Read
Central Bank Signals Matter—But These Forces Tell Us More
Focusing on a handful of words from the Fed chair risks overlooking what will shape economic paths and interest rates in the long term.
4 minute read
Treasury Yields Keep Climbing. The Dollar Might Tell Us Why.
Moves in the dollar are indicating yield rises are clearly a bad sign, Steven Kamin writes.
4 minute read
Bank of America CEO Sparks Bank Stock Selloff
Bank of America CEO Brian Moynihan said at a conference on Monday that sales and trading revenue for the fiscal third quarter will be “flat.”
1 minute read
Vanguard Conquered the ETF World. Where It’s Aiming Next.
Here’s how CEO Salim Ramji plans to bring the asset-management company’s low-cost, high-return formula to cash savings, financial advice, and active fixed income.
Long Read
Rent or Buy? What Seniors Are Doing—and Why.
More retirees are opting to walk away from home ownership. Some rent because high mortgage rates and others rent to have higher income and more flexibility to travel.
Long Read
Private Equity Is Buying Into Sports. Blue Pool’s Oliver Weisberg Explains Why Advisors Should Care.
Oliver Weisberg, the CEO of Blue Pool Capital and an investor in the Brooklyn Nets, explains the appeal of investing in sports teams.
Long Read
Once Red-Hot, M&A Activity is Dropping Among Financial Advice Firms
Registered investment advisor firms have been pursuing acquisitions to gain greater scale and efficiency.
2 minute read
Check out Barron's Advisor Rankings
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Find an Advisor
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Recently Viewed Tickers
SymbolPriceChange% Chg
U.S. Stock Movers
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| Kodiak Sciences Inc. (KOD) | 177.96% | $89.92 |
| Lifecore Biomedical Inc. (LFCR) | 55.24% | $6.52 |
| Enigmatig Ltd. (EGG) | 51.79% | $4.25 |
| ClearOne Inc. (CLRO) | 47.83% | $5.10 |
| YD Bio Ltd. (YDES) | 24.08% | $7.11 |